- Home
- ROIV vs AAL Comparison
ROIV vs AAL Comparison
Compare ROIV & AAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- AAL
- Stock Information
- Founded
- ROIV 2014
- AAL 1930
- Country
- ROIV United Kingdom
- AAL United States
- Employees
- ROIV N/A
- AAL N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- AAL Air Freight/Delivery Services
- Sector
- ROIV Health Care
- AAL Consumer Discretionary
- Exchange
- ROIV Nasdaq
- AAL Nasdaq
- Market Cap
- ROIV 8.6B
- AAL 8.7B
- IPO Year
- ROIV N/A
- AAL N/A
- Fundamental
- Price
- ROIV $14.18
- AAL $12.41
- Analyst Decision
- ROIV Strong Buy
- AAL Hold
- Analyst Count
- ROIV 4
- AAL 14
- Target Price
- ROIV $15.50
- AAL $14.46
- AVG Volume (30 Days)
- ROIV 6.8M
- AAL 77.2M
- Earning Date
- ROIV 11-11-2025
- AAL 10-23-2025
- Dividend Yield
- ROIV N/A
- AAL N/A
- EPS Growth
- ROIV N/A
- AAL N/A
- EPS
- ROIV N/A
- AAL 0.86
- Revenue
- ROIV $23,233,000.00
- AAL $54,250,000,000.00
- Revenue This Year
- ROIV N/A
- AAL $1.40
- Revenue Next Year
- ROIV $281.14
- AAL $6.03
- P/E Ratio
- ROIV N/A
- AAL $14.41
- Revenue Growth
- ROIV N/A
- AAL 1.50
- 52 Week Low
- ROIV $8.73
- AAL $8.50
- 52 Week High
- ROIV $14.48
- AAL $19.10
- Technical
- Relative Strength Index (RSI)
- ROIV 75.19
- AAL 44.06
- Support Level
- ROIV $13.81
- AAL $12.61
- Resistance Level
- ROIV $14.48
- AAL $13.23
- Average True Range (ATR)
- ROIV 0.43
- AAL 0.44
- MACD
- ROIV 0.17
- AAL -0.12
- Stochastic Oscillator
- ROIV 88.76
- AAL 13.34
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About AAL American Airlines Group Inc.
American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest fleet of US legacy carriers.